East TN family starts charitable foundation as daughter battles rare disease
KNOXVILLE, Tenn. (WATE) — It was a packed house at Yee-Haw Brewing in North Knoxville as hundreds gathered to show their support for the Begbie family and others who have children with Sanfilippo syndrome.
Rowan Begbie's parents, Bryan and Blair, said their daughter is fearless and loves her family as she battles this disease that's described as childhood Alzheimer's.
'She's so full of life. She loves people. She connects with people. She loves her siblings so incredibly much,' Bryan and Blair said. 'She's fearless, which can be a bad thing. Right now, she's just doing so well.'
Parents of slain teen advocate for mental health reform as suspect appears in court
Rowan, was diagnosed with Sanfilippo syndrome last year. The three-year-old and her family now making numerous trips to North Carolina to take part in a clinical trial.
'There's only about 12 kids in the U.S. receiving this specific treatment,' Bryan explained. 'We drive there the afternoon before infusions, then we have a full infusion day from 7:00 a.m. to 5:00 p.m. and then we drive home. We couldn't be happier with the team of physicians and nurses that care for her.'
What is Sanfilippo syndrome? It is a rare genetic disorder that affects the brain and spinal cord. This disorder impacts one in 50,000 to one in 250,000 people worldwide and has a variety of different symptoms.
'MPS, or mucopolysaccharidosis, is a metabolism disorder where Rowan does not produce the enzyme that breaks down a toxin that builds up in her body, primarily her brain, which leads to behavioral issues, cognitive decline and a number of other unfortunate symptoms.'
Knoxville woman faces eviction due to daughter's behavior at apartment complex
The Begbie family has started a foundation in Rowan's honor called the Rowan Tree Foundation of East Tennessee as a way to help raise money to find a treatment for Sanfilippo and help other families who have children with the disorder. Bryan and Blair said the support they have received, not just during the event, is incredible.
'It's overwhelming, we've seen friends and people from every corner of our lives show up for us over the last year and it's been absolutely amazing,' they said. 'We have super generous and talented people that surround us and love us that helped us put today together.'
The family told 6 News that there are five families in East Tennessee that have a child with Sanfilippo syndrome. Bryan said they initially got a call from a mutual friend with concern about Rowan on April 1 last year. They did the genetic testing which showed the mutation for the disease, and she was officially diagnosed on April 26.
▶ See more top stories on WATE.com
Money spent tonight on merchandise, silent auction and drinks will go toward research for Sanfilippo syndrome.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
a day ago
- Business Insider
It's not just for gyms bros — scientists say a 50-cent muscle-building supplement slows aging and may counteract Alzheimer's
Creatine — long beloved by gym rats who mix it into protein shakes — is shaping up to be much more than a muscle building and fat loss supplement. Mounting research suggests it may also boost heart health, protect against Alzheimer's, improve mood, and strengthen your bones. While researchers typically have a healthy mistrust of supplements, creatine is the rare exception, recommended even among skeptical scientists and doctors: it's reliably safe, relatively inexpensive, and backed by extensive, high-quality studies. And it costs, on average, less than 50 cents per serving. "I don't know if there's anything on the planet that comes close to creatine from a multifactorial approach," Darren Candow, a top creatine researcher and professor of exercise physiology, nutrition and aging at Regina University in Canada, told Business Insider. Over the past decade, interest in creatine has skyrocketed, in tandem with research showing it can double up as a longevity supplement. As of May, the US creatine market is worth $456.6 million, up 36% from the prior year, according to data and analytics company Spins. "As much as we can define a longevity supplement at this point, creatine is probably one of the best in that category," Jordan Glen, supplement researcher and chief science officer for health startup SuppCo., an app that helps users find the right supplements for their goals, told Business Insider. Creatine drives your muscles to push harder without getting tired Creatine was first discovered in muscle tissue in 1832. Nearly a century later, scientists started to figure out how it's stored and used for energy in the human body. They experimented with extracting creatine from meat and later synthesizing it in a lab. But it wasn't until the Barcelona Olympic Games in 1992 that creatine went mainstream. The British gold-medal sprinters, sharing how they got in shape, gushed about the powerful effects of a little-known supplement: creatine. In 1993, the first commercial creatine hit store shelves, and sales boomed. Creatine is a raw material for producing ATP, a molecule that gives our cells energy. The majority of creatine is stored in the muscles, where it offers a ready fuel source for high-intensity effort. More creatine can improve strength and muscle gains by providing a bit more energy, helping you push a little bit harder and work out for longer before getting tired. Our bodies naturally produce creatine through a combination of amino acids. That's only a small amount, though. We can get more of it from some foods like red meat and fish — or, through supplements. In the past five years, demand for creatine as a fitness aid has spiked, with retail prices up 150% and sales increased by 90% year over year, despite steadily rising costs. And it's not just for muscle-hungry gym bros. While men continue to make up the majority of creatine users, about 21% of the creatine buyers are women, according to data from nationwide supplement retailers The Vitamin Shoppe. At SuppCo, both Glen, the CSO, and Steve Martocci, the CEO, said their wives have recently started taking creatine — reflecting a broader trend of women as a growing consumer base. What changed? Martocci pointed to more evidence dispelling the myth that creatine is just for muscle men to bulk up. Plus, early research suggests creatine can support hormonal health for women, helping to counteract shifts that can occur during the menstrual cycle by helping to maintain levels of glycogen in the muscle for better energy and performance. Creatine slows aging and boosts brain health, per new research In June, a small study found that patients with Alzheimer's disease saw a boost to their cognitive function after supplementing creatine. "We think that just providing more energy to the brain could be useful," Scott Forbes, a sports science researcher and professor at Brandon University who was not involved in the study, told Business Insider. "The brain actually uses about 20% of your total energy expenditure, even though it only weighs about 2% of your body weight. So for a tissue, it's very energetically demanding," Forbes said. Creatine also seems to have an anti-inflammatory effect, making the brain more resilient against stresses that would wear down its ability to perform. "We know that too much inflammation or too much oxidative stress can also lead to poor cognition or poor brain functions," Forbes said. Other recent studies have found that supplementing creatine could also help to mitigate the effects of aging or a concussion. "The theory is that the brain can remodel itself or at least maintain its function during times of stress," Candow, the aging researcher at Regina University, told Business Insider. "I don't know anybody in the world that's not stressed." The new research is expanding creatine's reach to consumers beyond the gym, according to Muriel Gonzalez, president of nationwide supplement retailer The Vitamin Shoppe. "Creatine is undergoing a major transformation — from a niche sports nutrition supplement to a versatile tool for daily health and longevity," Gonzalez told Business Insider over email. Total creatine sales have spiked by 300% from 2019 to 2024 at The Vitamin Shoppe, and are continuing to grow at a double-digit pace, according to company data. Should you be taking creatine? You'll be disappointed if you expect to transform your life, and health, with a few doses of creatine. A supplement can provide a boost but ultimately makes a relatively small difference. Your overall diet, exercise, and lifestyle are far more important. Still, the bottom line is that more and more research supports taking creatine for a huge range of benefits, with very little downside. "I think almost everybody should consider taking creatine," Forbes, the science researcher at Brandon University, said. Even in high doses over a long time period, side effects are mild, such as gastrointestinal upset and a slight increase in water retention, since creatine pulls water into the muscles. "Overall it's one of the safest supplements out there," Eric Gonzalez, a neuroscience professor at Texas Christian University who has studied creatine, told Business Insider. "If anyone wants to go on a supplement, creatine won't hurt you, there's only going to be an upside." If you're losing weight — including those on a GLP-1 drug that triggers weight loss — creatine can help you retain muscle mass, promoting a higher ratio of muscle to body fat. For those looking to boost brain health or mood, early studies suggest that 10-30 grams a day may be beneficial. Glen previously conducted research on senior Olympians who took creatine and found it helped them get stronger and faster while avoiding age-related decline. "We're never too old to take creatine," he said.
2 days ago
Diabetes drug may cut migraine days in half with little weight loss: Study
Drugs in the same family as Ozempic and Wegovy are known for treating diabetes and helping with weight loss, but a small, early-stage study suggested they might also ease migraines -- even when there's no weight loss. The benefit appears to come from lowering pressure in the brain, Dr. Simone Braca, a neurologist at the University of Naples Federico II and lead author of the study, explained to ABC News. 'This study is very interesting in that the GLP 1s are hypothesized to lower brain pressure, which can then lower your chance of getting a headache or a migraine,' Braca said. The small, 12-week study tracked 26 adults with obesity who had chronic or frequent migraines. Published in Headache -- the official journal of the American Headache Society -- and presented at this week's European Academy of Neurology meeting in Finland, it tested liraglutide, a type of GLP-1 drug commonly used for diabetes and weight loss. After taking a daily 1.8 mg dose of liraglutide for three months -- the amount typically used to treat diabetes -- their average number of headache days per month dropped from 20 to about nine. Participants also reported less disability from migraines, with scores on a standard headache impact scale cut by more than half. Although some participants lost a small amount of weight, Braca said the few lost pounds were not meaningful enough to explain the improvement in migraines. Instead, Braca pointed to pressure from cerebrospinal fluid -- the liquid that surrounds and cushions the brain and spine. He said he believes that even slight buildups of this fluid can press on nearby veins and nerves in the brain, potentially triggering migraines. 'An increased pressure of the spinal fluid in the brain may be one of the mechanisms underlying migraine,' Braca said. 'And if we target this mechanism, this preliminary evidence suggests that it may be helpful for migraine.' Nearly half of patients reported at least a 50% reduction in headache days, according to the Headache paper. About 40% experienced mild side effects like nausea or constipation. None stopped taking the medication. With such promising results, Braca and his research team, led by Dr. Roberto De Simone, are already planning larger trials. Future studies will measure brain pressure more directly and explore whether other GLP 1 drugs might also offer the same relief but with fewer side effects. 'There are still a substantial portion of migraine patients that face an unmet need and that live with its burden,' he said. 'New drugs that could target other pathways, I think that could be reassuring to those patients and give them hope.' The study adds to growing evidence that GLP-1 drugs may have benefits beyond diabetes and weight loss. Researchers are already studying these medications for a range of other conditions, including reducing the risk of heart disease and stroke, easing symptoms of addiction and treating Alzheimer's disease.
Fox News
2 days ago
- Fox News
Bill Gates reveals 'next phase of Alzheimer's fight' as he shares dad's personal battle
Bill Gates is speaking out about his personal experience with Alzheimer's — and his hope for progress in fighting the disease. In an essay published this week on his blog at the Microsoft co-founder and tech billionaire, 69, reflected on the difficulty of spending another Father's Day without his dad, Bill Gates Sr. The elder Gates passed away in 2020 at the age of 94 after battling Alzheimer's. "It was a brutal experience, watching my brilliant, loving father go downhill and disappear," Gates wrote in the blog post. Today, motivated by his own experience with the common dementia, Gates — who serves as chair of the Gates Foundation — is committed to working toward a cure for the common dementia, which currently affects more than seven million Americans, or one in nine people over 65. In his blog, Gates expressed optimism about the "massive progress" being made in the fight against Alzheimer's and other dementias. Last year, Gates said he visited Indiana University's School of Medicine in Indianapolis to tour the labs where teams have been researching Alzheimer's biomarkers. "I also got the opportunity to look under the hood of new automated machines that will soon be running diagnostics around the world," he wrote. "It's an exciting time in a challenging space." One of the biggest breakthroughs in Alzheimer's research, according to Gates, is blood-based diagnostic tests, which detect the ratio of amyloid plaques in the brain. (Amyloid plaques, clumps of protein that accumulate in the brain, are one of the hallmarks of Alzheimer's.) "I'm optimistic that these tests will be a game-changer," Gates wrote. Last month, the U.S. Food and Drug Administration (FDA) approved the first blood-based test for patients 55 years and older, as Fox News Digital reported at the time. "A simple, accurate and easy-to-run blood test might one day make routine screening possible." Traditionally, Gates noted, the primary path to Alzheimer's diagnosis was either a PET scan (medical imaging) or spinal tap (lumbar puncture), which were usually only performed when symptoms emerged. The hope is that blood-based tests could do a better job of catching the disease early, decline begins. "We now know that the disease begins 15 to 20 years before you start to see any signs," Gates wrote. "A simple, accurate and easy-to-run blood test might one day make routine screening possible, identifying patients long before they experience cognitive decline," he stated. Gates said he is often asked, "What is the point of getting diagnosed if I can't do anything about it?" To that end, he expressed his optimism for the future of Alzheimer's treatments, noting that two drugs — Lecanemab (Leqembi) and Donanemab (Kisunla) — have gained FDA approval. "Both have proven to modestly slow down the progression of the disease, but what I'm really excited about is their potential when paired with an early diagnostic," Gates noted. He said he is also hopeful that the blood tests will help speed up the process of enrolling patients in clinical trials for new Alzheimer's drugs. To accomplish this, Gates is calling for increased funding for research, which often comes from federal grants. "This is the moment to spend more money on research, not less," he wrote, also stating that "the quest to stop Alzheimer's has never had more momentum." "There is still a huge amount of work to be done — like deepening our understanding of the disease's pathology and developing even better diagnostics," Gates went on. "I am blown away by how much we have learned about Alzheimer's over the last couple of years." Gates pointed out that when his father had Alzheimer's, it was considered a "death sentence," but that is starting to change. "I am blown away by how much we have learned about Alzheimer's over the last couple of years," he wrote. For more Health articles, visit "I cannot help but be filled with a sense of hope when I think of all the progress being made on Alzheimer's, even with so many challenges happening around the world. We are closer than ever before to a world where no one has to watch someone they love suffer from this awful disease."
